Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Bol

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
EJNMMI Research|March 25, 2016
αVβ3 integrin-targeted microSPECT/CT imaging of inflamed atherosclerotic plaques in miceDavid Vancraeynest, Véronique Roelants, Caroline Bouzin, et al.
Oncotarget|July 10, 2018
2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neckLionel Mignion, Sandra Schmitz, Nicolas Michoux, et al.
Nanomedicine (London, England)|February 20, 2014
(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapyLinda Karmani, Virginie Bouchat, Caroline Bouzin, et al.
Neoplasia (New York, N.Y.)|November 28, 2016
Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In VivoMarie-Aline Neveu, Géraldine De Preter, Valérie Marchand, et al.
Contrast Media & Molecular Imaging|June 7, 2013
Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in miceLinda Karmani, Daniel Labar, Vanessa Valembois, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
EJNMMI Research|March 25, 2016
αVβ3 integrin-targeted microSPECT/CT imaging of inflamed atherosclerotic plaques in miceDavid Vancraeynest, Véronique Roelants, Caroline Bouzin, et al.
Oncotarget|July 10, 2018
2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neckLionel Mignion, Sandra Schmitz, Nicolas Michoux, et al.
Nanomedicine (London, England)|February 20, 2014
(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapyLinda Karmani, Virginie Bouchat, Caroline Bouzin, et al.
Neoplasia (New York, N.Y.)|November 28, 2016
Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In VivoMarie-Aline Neveu, Géraldine De Preter, Valérie Marchand, et al.
Contrast Media & Molecular Imaging|June 7, 2013
Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in miceLinda Karmani, Daniel Labar, Vanessa Valembois, et al.
Pageof 6